Bank of New York Mellon Corp
BankPosition in BCRX — Biocryst Pharmaceuticals Inc
CIK 1390777
NEW YORK, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,804,810
+$734,307 QoQ
Shares Held
680,481
+6.7% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. BCRX ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,804,810 | 680,481 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $6,070,503 | 637,658 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,742,336 | 607,992 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,705,707 | 619,988 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $5,489,414 | 612,658 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $4,424,076 | 589,877 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $4,488,971 | 596,938 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $4,535,967 | 596,838 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,795,412 | 775,957 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,503,715 | 689,708 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $4,504,388 | 751,985 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $5,434,401 | 767,571 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $5,346,765 | 759,484 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $5,592,869 | 670,608 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $7,772,211 | 677,022 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,459,789 | 671,412 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,558,233 | 619,871 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,505,674 | 892,108 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $11,882,357 | 857,932 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,746,185 | 747,821 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $11,672,727 | 738,313 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $7,270,542 | 714,901 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,647,858 | 758,102 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,498,932 | 726,434 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,955,168 | 830,918 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $1,301,276 | 650,638 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||